Presently, Howard Mayer is Executive VP, Head-Research & Development at Ipsen Pharmaceuticals, Inc. and Executive Vice President-Research & Development at Ipsen SA. He is also on the board of Melmark Charitable Foundation, Entasis Therapeutics Holdings, Inc. and Adagio Therapeutics, Inc. In the past Dr. Mayer was Head-Clinical Development & Medical Affairs at Pfizer Inc., Director-Infectious Diseases Clinical Research at Bristol Myers Squibb Co., Chief Medical Officer, Senior VP, Head-R&D at Shire Plc, Chief Medical Officer for EMD Serono, Inc. and Head-Rare Disease Business Unit, R&D at Takeda Pharmaceuticals U.S.A., Inc. He received an undergraduate degree from the University of Pennsylvania and a doctorate from Albert Einstein College of Medicine, Inc.